Understanding GABA(B): Potential Drug Target and Biomarker for Psychiatric Disorders

Target Name: Gamma-Aminobutyric acid type B receptor

NCBI ID: P10238

Gamma-Aminobutyric acid type B receptor

Other Name(s): GABA(B) | GABA(B)-R

Understanding GABA(B): Potential Drug Target and Biomarker for Psychiatric Disorders

Gamma-Aminobutyric acid type B receptor (GABA(B)) is a G protein-coupled receptor that plays a crucial role in various physiological processes in the body. It is a transmembrane receptor that is located in the brain and nervous system, and it is involved in the regulation of a wide range of physiological processes, including sleep, appetite, and mood.

GABA(B) is one of the most abundant G protein-coupled receptors, and it is expressed in many different tissues and cells in the body. It is a purported modulator of various intracellular signaling pathways, including the modulation of ion channels, neurotransmitter signaling , and gene expression.

Despite its importance in many different physiological processes, GABA(B) is not well understood, and there are limited research studies available on its biology. However, its potential role as a drug target or biomarker is of interest to researchers, as it may have therapeutic potential in various psychiatric and neurological disorders.

One potential mechanism by which GABA(B) could be targeted as a drug is through its modulation of pain perception. GABA(B) is known to play a role in the regulation of pain signaling, and it is thought to have a negative effect on pain perception. This may be because GABA(B) signaling is involved in the regulation of neurotransmitter release, which is involved in pain signaling.

Another potential mechanism by which GABA(B) could be targeted as a drug is through its modulation of anxiety and depression. GABA(B) is known to be involved in the regulation of anxiety and depression, and it is thought to play a negative role in these disorders. This may be because GABA(B) signaling is involved in the regulation of neurotransmitter release, which is involved in the regulation of anxiety and depression.

In addition to its potential role as a drug target, GABA(B) may also be used as a biomarker for certain psychiatric and neurological disorders. For example, GABA(B) levels have been measured in individuals with depression and anxiety, and low GABA (B) levels have been associated with increased risk of these disorders. Additionally, GABA(B) has been shown to be involved in the regulation of various physiological processes, including sleep and appetite, which may be useful as biomarkers for certain psychiatric disorders.

Overall, GABA(B) is a G protein-coupled receptor that plays a crucial role in various physiological processes in the body. While its potential role as a drug target or biomarker is still being explored, its study is significant for our understanding of its biology and potential therapeutic applications.

Protein Name: Gamma-Aminobutyric Acid Type B Receptor

The "Gamma-Aminobutyric acid type B receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Gamma-Aminobutyric acid type B receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets